Cargando…
A case of antithrombin replacement using recombinant human antithrombin in an adult patient supported with extracorporeal membrane oxygenation
In the critically ill patient on extracorporeal life support, antithrombin production and activity can be decreased and may require replacement to therapeutic levels in order to maintain appropriate anticoagulation and prevent thrombosis.
Autor principal: | Lavandosky, Gerald J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551329/ https://www.ncbi.nlm.nih.gov/pubmed/26331016 http://dx.doi.org/10.1002/ccr3.312 |
Ejemplares similares
-
Use of recombinant human antithrombin concentrate in pregnancy
por: Kreuziger, Lisa M Baumann, et al.
Publicado: (2013) -
Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers
por: Furuie, Hidetoshi, et al.
Publicado: (2019) -
Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial
por: Panigada, Mauro, et al.
Publicado: (2019) -
Acute Portal Vein Thrombosis Treated with Recombinant Human Soluble Thrombomodulin Combined with Antithrombin III
por: Nakayama, Satoshi, et al.
Publicado: (2020) -
Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)